Vascular endothelial growth factor (VEGF) therapy in metastatic renal cell carcinoma (mRCC): Differences between Asian and non-Asian patients.
Ying Wang(Henan University), Daniel Yick Chin Heng(University of Calgary), Toni K. Choueiri(Harvard University), Scott North, Sun Young Rha(Yonsei University), Christian Kollmannsberger(BC Cancer Agency), Jae‐Lyun Lee(Ulsan College), Min‐Han Tan(National Cancer Centre Singapore)
Cited by 1
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k